Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Synnovation Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Synnovation Therapeutics

Synnovation Therapeutics

Series A

Synnovation Therapeutics: Precision oncology firm specializing in small molecule therapies for cancer.

HQ
Wilmington, DE, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Synnovation Therapeutics, a precision oncology company, was founded with the mission to discover and develop small molecule therapies that target key driver mechanisms in cancer. The company's vision is to transform science and improve lives by creating best-in-class therapeutics for cancer patients. Their market focus is on precision medicine, leveraging deep expertise in cancer biology and medicinal chemistry to build a diverse pipeline of novel small molecules optimized for highly validated disease targets.

Notable affiliated people include a world-class team of experts in medicinal chemistry and cancer biology. Synnovation Therapeutics has attracted significant investment from leading venture capital firms in the biotech sector, underscoring its potential impact. Key achievements include the development of a robust pipeline of promising small molecule therapies. The company's overall impact lies in its commitment to advancing precision oncology, aiming to significantly improve treatment outcomes for cancer patients.

Synnovation Therapeutics - Similar Companies

NiKang Therapeutics logo

NiKang Therapeutics

Nested Therapeutics logo

Nested Therapeutics

nestedtx.com

Alphina Therapeutics logo

Alphina Therapeutics

Nexo Therapeutics logo

Nexo Therapeutics

nexotx.com

Traws Pharma logo

Traws Pharma

Scorpion Therapeutics logo

Scorpion Therapeutics

Alterome Therapeutics logo

Alterome Therapeutics

alterome.com

Innovo Therapeutics logo

Innovo Therapeutics

SynerGene Therapeutics logo

SynerGene Therapeutics

Odyssey Therapeutics logo

Odyssey Therapeutics

Window Therapeutics logo

Window Therapeutics

windowtx.com

Signet Therapeutics logo

Signet Therapeutics

OncoPrecision logo

OncoPrecision

oncoprecision.bio

OnCusp Therapeutics logo

OnCusp Therapeutics

oncusptx.com

OncXerna Therapeutics logo

OncXerna Therapeutics

oncxerna.com

Synnovation Therapeutics - Quick Facts

Who are Synnovation Therapeutics' competitors?

Companies similar to Synnovation Therapeutics include NiKang Therapeutics, Nested Therapeutics, Alphina Therapeutics and Nexo Therapeutics.

When was Synnovation Therapeutics founded?

Synnovation Therapeutics was founded in 2021.

Where is Synnovation Therapeutics' headquarters located?

Synnovation Therapeutics' headquarters is located in Wilmington, DE, US.

When was Synnovation Therapeutics' last funding round?

Synnovation Therapeutics' most recent funding round was for $102M (USD) in December 2023.

How much has Synnovation Therapeutics raised to-date?

As of Dec 14, 2023, Synnovation Therapeutics has raised a total of $139M (USD).

How many employees does Synnovation Therapeutics have?

Synnovation Therapeutics has 18 employees as of Feb 5, 2024.

Synnovation Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Oncology Therapies
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified